Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis

Clinical trial NCT05205603 · COMPLETED

Trial details

NCT number: NCT05205603
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Ulcerative Colitis Efficacy, Self Biologics Mesalazine

Start date: 2022-01-15
Primary completion: 2024-01-15
Enrollment: 438

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.